Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Acetonide vs Prednisolone Acetate for Postoperative Inflammation After Cataract Surgery
NCT07567118Completed
- Sponsor
- Damascus University
- Start
- May 2023
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of triamcinolone in post-operative ocular inflammation (2 arms), sponsored by Damascus University. Primary endpoint: Degree of postoperative ocular inflammation at 1 month. Started May 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT07567118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567118.